FDA says it will conduct less than half of the drug, device inspections it planned for 2021

Citing restrictions related to the pandemic, the FDA will perform less than half of the non-food domestic surveillance inspections it had planned for fiscal year 2021, the agency said May 5.

Advertisement

The FDA said that as of March, 3,229 non-food domestic inspections still needed to be conducted before Sept. 30, when fiscal year 2021 ends. It said it is unsure how many of those inspections it will be able to perform, as uncertainties about travel restrictions remain.

The agency said if it returns to standard inspection procedures by mid-summer, it will conduct just 851 non-food domestic inspections, 26 percent of the non-food domestic inspections remaining for fiscal year 2021.

FDA Deputy Commissioner for Food Policy and Response Frank Yiannas told Politico the agency is uncertain when its domestic inspection operations will fully return to normal, as it “depends on what happens with the pandemic, the virus and whether variants emerge.”

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Beyond the bottleneck: How health systems are improving access, flow and care continuity

Thursday, July 30
1:00 PM - 2:00 PM CDT

Presenters: Imamu Tomlinson, MD, MBA, VituityWilliam Morice II, MD, PhD, Mayo Clinic LaboratoriesJordan Dale, MD, Houston MethodistAsh Tengshe, City of HopeChris Klay, MHA, MA, PT, FACHE, Hospital Sisters Health System

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.